Lobbying and Lobbyists

September 15, 2022

FDA’s drug industry fees are raising concerns about influence

The pharmaceutical industry funds about 75 percent of the agency’s drug division through a controversial program that must be re-approved by Congress by the end of this month. Source link
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more